Affimed Shares Preclinical Data on Mechanism of Action of two Innate Cell Engagers at the 36th SITC Meeting, Demonstrating their Potential to Induce Antibody Dependent Cellular Phagocytosis and Serial
Go back to Affimed Shares Preclinical Data on Mechanism of Action of two Innate Cell Engagers at the 36th SITC Meeting, Demonstrating their Potential to Induce Antibody Dependent Cellular Phagocytosis and Serial| (NASDAQ: AFMD) | Delayed: 0.18 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.18 | 52 Week High | $8.26 | |||
| Open | $0.18 | 52 Week Low | $1.75 | |||
| Day High | $0.18 | P/E | N/A | |||
| Day Low | $0.18 | EPS | $0.00 | |||
| Volume | 2,198 | |||||
